Tumor necrosis factor α-gene therapy for an established murine melanoma using RGD (Arg-Gly-Asp) fiber-mutant adenovirus vectors

Japanese Journal of Cancer Research

Volumn 93, Issue 4, 2002, Pages 436-444

  Okada, Yuka ^a   Okada, Naoki ^b   Nakagawa, Shinsaku ^c   Mizuguchi, Hiroyuki ^d   Takahashi, Koichi ^a   Mizuno, Nobuyasu ^a   Fujita, Takuya ^b   Yamamoto, Akira ^b   Hayakawa, Takao ^d   Mayumi, Tadanori ^c  

^a MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Adenovirus vector; Fiber mutant; Gene therapy; Melanoma; Tumor necrosis factor

Indexed keywords

ADENOVIRUS VECTOR; ALPHA5 INTEGRIN; ARGINYLGLYCYLASPARTIC ACID; BETA ACTIN; BETA3 INTEGRIN; BETA5 INTEGRIN; COMPLEMENTARY DNA; CYTOKINE; IMMUNOGLOBULIN G; LIPOSOME; MONOCLONAL ANTIBODY; PEPTIDE; PROTEIN ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER MODEL; CELL TYPE; CONTROLLED STUDY; COXSACKIE VIRUS; DRUG BLOOD LEVEL; DRUG EFFICACY; EXPERIMENTAL MELANOMA; GENE TARGETING; GENETIC TRANSDUCTION; HEMOLYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DENATURATION; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CRICETINAE; ENTEROVIRUS; FLOW CYTOMETRY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; INTEGRIN ALPHAV; LAC OPERON; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MUTATION; NECROSIS; OLIGOPEPTIDES; POLYMERASE CHAIN REACTION; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 18344386980     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2002.tb01275.x     Document Type: Article

References (41)

1. Ultraviolet A and melanoma: A review
2. The paradoxical association of regression with a poor prognosis in melanoma contrasted with a good prognosis in keratocanthoma
3. Locally recurrent malignant melanoma characteristics and outcomes: A single-institution study
4. A safe, effective in vivo gene therapy for melanoma using tyrosinase promoter-driven cytosine deaminase gene
5. Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer
6. Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity
7. Effective tumor therapy with plasmid-encoding cytokines combined with in vivo electroporation
8. In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term anti-tumor immunity
9. Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patients
10. Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor
11. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and anti-tumor efficacy in leukemia and solid tumors in mice
12. Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach
13. Gene therapy for metabolic disorders
14. Gene therapy: Adenovirus vectors
15. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5
16. 5 promote adenovirus internalization but not virus attachment
17. The presence of human coxsackie virus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures
18. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob
19. Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors
20. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate anti-tumor vaccine efficacy and maturation of murine dendritic cells
21. Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method
22. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors
23. Tumor necrosis factor α-mediated tumor regression by the in vivo transfer of genes into the artery that leads to tumors
24. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12
25. Fluorescent virions: Dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells
26. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumours
27. Transduction of a fiber-mutant adenovirus for the HSVtk gene highly augments the cytopathic effect towards gliomas
28. Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma
29. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo
30. Gene therapy for colon cancer
31. Tumour necrosis factor. Characterization at the molecular, cellular and in vivo level
32. Tumour necrosis factor and cancer
33. Antitumor activity of tumor necrosis factor-alpha conjugated with polyvinylpyrrolidone on solid tumors in mice
34. Selective enhancement by tumor necrosis factor-α of vascular permeability of new blood vessels induced with agarose hydrogel-entrapped Meth-A fibrosarcoma cells
35. Phase I clinical trial of recombinant human tumor necrosis factor
36. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies
37. Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105)
38. Targeted gene delivery by tropism-modified adenoviral vectors
39. Molecular adaptors for vascular-targeted adenoviral gene delivery
40. v-integrins
41. Enhancement of adenoviral transduction with polycationic liposomes in vivo